SAA2 and atherosclerosis: Even a single injection of the adenoviral vector encoding SAA1, resulting in only a brief elevation of circulating SAA, was sufficient to increase atherosclerosis in apoE-/- mice in the immune-tolerant recombination activating gene-1-deficient background [87].